WallStreetZenWallStreetZen

NASDAQ: KYMR
Kymera Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KYMR past revenue growth

How has KYMR's revenue growth performed historically?
Company
67.84%
Industry
148.64%
Market
17.33%
KYMR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KYMR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KYMR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KYMR earnings and revenue history

Current Revenue
$78.6M
Current Earnings
-$147.0M
Current Profit Margin
-187%

KYMR Return on Equity

Current Company
-34.8%
Current Industry
-63.5%
Current Market
188%
KYMR's Return on Equity (-34.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KYMR announces earnings.

KYMR Return on Assets

Current Company
-25.3%
Current Industry
2.9%
KYMR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KYMR Return on Capital Employed

Current Company
-29.95%
Current Industry
19.5%
KYMR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KYMR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KYMR$78.59M-$143.20M-$146.96M+127.50%N/A
TGTX$233.66M$25.89M$12.67M+333.86%N/A
VERA$0.00-$94.07M-$95.99MN/AN/A
RCKT$0.00-$236.62M-$245.60MN/AN/A
VCEL$197.52M$8.93M-$3.18M+16.80%N/A
View Top Biotech Stocks

KYMR earnings dates

Next earnings date
May 2, 2024

Kymera Therapeutics Earnings & Revenue FAQ

What were KYMR's earnings last quarter?

On Invalid Date, Kymera Therapeutics (NASDAQ: KYMR) reported Q4 2023 earnings per share (EPS) of -$0.25, up 57.63% year over year. Total Kymera Therapeutics earnings for the quarter were -$14.37 million. In the same quarter last year, Kymera Therapeutics's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Kymera Therapeutics stock.

What was KYMR's earnings growth in the past year?

As of Q2 2024, Kymera Therapeutics's earnings has grown year over year. Kymera Therapeutics's earnings in the past year totalled -$146.96 million.

What is KYMR's earnings date?

Kymera Therapeutics's earnings date is Invalid Date. Add KYMR to your watchlist to be reminded of KYMR's next earnings announcement.

What was KYMR's revenue last quarter?

On Invalid Date, Kymera Therapeutics (NASDAQ: KYMR) reported Q4 2023 revenue of $47.89 million up 196.7% year over year. In the same quarter last year, Kymera Therapeutics's revenue was $16.14 million.

What was KYMR's revenue growth in the past year?

As of Q2 2024, Kymera Therapeutics's revenue has grown 67.84% year over year. This is 80.8 percentage points lower than the US Biotechnology industry revenue growth rate of 148.64%. Kymera Therapeutics's revenue in the past year totalled $78.59 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.